Treatment with L-Citrulline in patients with post-polio syndrome: A single center, randomized, double blind, placebo-controlled trial.
- 2021-11
- RCT
- Neuromuscular disorders : NMD 31(11)
- Niveditha Putananickal
- Anna-Lena Orsini
- Simone Schmidt
- Vanya Gocheva
- Daniela Rubino
- Tanja Haas
- Sabine Schädelin
- Xeni Deligianni
- Oliver Bieri
- Dirk Fischer
- Patricia Hafner
- PubMed: 34711479
- DOI: 10.1016/j.nmd.2021.08.011
- High evidence
- Clinical
Patients receiving L-Citrulline walked 17.5 longer in the 6 min walking distance test when compared to placebo group, however not statistically significant (95% CI = -14.69; 49.68, p = 0.298)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 15 g/day